Safety Study of a Refrigerator-stable Formulation of VARIVAX®

Exclusion Criteria

• •1. Prior receipt of measles, mumps, rubella or varicella vaccine either alone or in combination vaccine,
• •2. Known or suspected clinical history of infection with measles, mumps, rubella, varicella or zoster,
• •3. Any known recent (≤30 days) exposure to measles, mumps or rubella,
• •4. Any known recent (≤30 days) exposure to varicella or zoster involving:
• •5. Any recent (≤3 days) history of febrile illness (rectal temperature ≥38.0°C),
• •6. Active untreated tuberculosis,
• •7. Any known blood dyscrasia, leukemia, lymphomas of any type, or other malignant neoplasms affecting the bone marrow or lymphatic systems,
• •8. Any immune impairment or humoral/cellular deficiency, neoplastic disease or depressed immunity,
• •9. Any previous (≤150 days) receipt of immune serum globulin or any blood-derived products or scheduled to be administered through visit 3,
• •10. Any recent receipt of an inactivated or a live vaccine (≤ 30 days) or scheduled vaccination through visit 3